Active Ingredient History

  • Now
Strontium ranelate, a strontium(II) salt of ranelic acid, is a medication for osteoporosis marketed as Protelos or Protos by Servier. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA).   Wikipedia

  • SMILES: [Sr+2].[Sr+2].[O-]C(=O)CN(CC(=O)[O-])c1sc(C(=O)[O-])c(CC(=O)[O-])c1C#N
  • Mol. Mass: 513.49
  • ALogP: -0.08
  • ChEMBL Molecule:
More Chemistry
3-(3-cyano-4-carboxymethyl-5-carboxy-2-thienyl)-3-azapentanedioic distrontium salt | bivalos | distrontium renelate | osseor | protelos | s12911 | s 12911 | s-12911 | s12911-0 | s12911-2 | s12911-5 | strontium ranelate


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue